Sensus Healthcare, Inc.

8-K · g085761_8k.htm

0001494891

 2026-06-02
 2026-06-02

 iso4217:USD

 xbrli:shares

 iso4217:USD

 xbrli:shares

   

 UNITED
STATES

 SECURITIES
AND EXCHANGE COMMISSION

 WASHINGTON,
DC 20549

 ____________________

  

 FORM
 8-K

  

 CURRENT
REPORT

  

 Pursuant
to Section 13 or 15(d) of the

 Securities
Exchange Act of 1934

 Date
of Report (Date of earliest event reported): June 2, 2026

  

 SENSUS
HEALTHCARE, INC.

 (Exact
name of registrant as specified in its charter)

 Delaware

  
 001-37714

  
 27-1647271

 (State
 of Incorporation)
  
 (Commission
 File Number)
  
 (IRS
 Employer Identification No.)

 851
 Broken Sound Pkwy. , NW # 215 , Boca Raton , Florida

  
 33487

 (Address
 of principal executive offices)
  
 (Zip
 Code)

 Registrant's
telephone number, including area code: (561) 922-5808

 _________________________________________________

 (Former
Name or Former Address, if Changed Since Last Report)

 Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):

   ☐
 Written communications pursuant to
 Rule 425 under the Securities Act (17 CFR 230.425)

  
  

   ☐
 Soliciting material pursuant to Rule 14a-12 under the
 Exchange Act (17 CFR 240.14a-12)

  
  

   ☐
 Pre-commencement communications pursuant to Rule 14d-2(b)
 under the Exchange Act (17 CFR 240.14d-2(b))

  
  

   ☐
 Pre-commencement communications pursuant to Rule 13e-4(c)
 under the Exchange Act (17 CFR 240.13e-4(c))

  

 Securities
registered pursuant to Section 12(b) of the Act:

 Title
 of each class
 Trading
 Symbol(s)
 Name
 of each exchange on which registered

 Common Stock, par value $0.01 per share
 SRTS
 Nasdaq Stock Market, LLC

 Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 Emerging
growth company ☐

 If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    

  

 SENSUS
HEALTHCARE, INC.

 FORM
8-K

 CURRENT
REPORT

 Item 1.01 Entry
 into a Material Definitive Agreement.

  

 On
June 2, 2026, Sensus Healthcare, Inc. (the “Company”) entered into a Loan Agreement (the “Loan Agreement”) with
City National Bank of Florida (“CNB”) pursuant to which CNB has made available to the Company a revolving credit facility
providing for maximum borrowings of $15,000,000 (the “Loan”), which is evidenced by a Revolving Promissory Note, dated June
2, 2026 (the “Note”), made by the Company in favor of CNB. Pursuant to the terms of the Note, advances made under the Loan
bear interest at the Secured Overnight Financing Rate plus 3% per annum and have a maturity date of June 5, 2027 unless extended by mutual
agreement of the Company and CNB. Pursuant to a Pledged Collateral and Restricted Account Agreement, dated June 2, 2026 (the “Pledged
Collateral Agreement”), between the Company and CNB, the Loan is secured by cash collateral in the amount of $2,230,000, and pursuant
to a Security Agreement, dated June 2, 2026 (the “Security Agreement”), between the Company and CNB, the Loan is secured
by a security interest in all of the Company’s assets (the “Collateral”).

  

 Under
the Loan Agreement, the Company must obtain CNB’s prior written consent in order to take any of the following actions: (a) sell
or transfer any of the Company’s assets outside the ordinary course of its business; (b) incur, create, assume, or permit to exist
any other indebtedness (subject to certain exceptions); (c) encumber any of the Company’s assets with any liens other than liens
in favor of CNB and certain other permitted liens, or (d) remove the Company’s current Chief Executive Officer, President or Chief
Financial Officer. The Loan Agreement contains a financial covenant requiring that the Company maintain a minimum debt service coverage
ratio of 1.50. The Loan Agreement also contains customary representations and warranties and customary events of default, upon the occurrence
of which, after any applicable grace period, CNB would have the ability to accelerate all outstanding advances, terminate the Loan, and
exercise remedies with respect to the Collateral.

  

 This
description of the Loan Agreement, Note, Pledged Collateral Agreement, and Security Agreement is qualified in its entirety by reference
to the Loan Agreement, Note, Pledged Collateral Agreement, and Security Agreement, which are attached as Exhibits 10.1, 10.2, 10.3, and
10.4, respectively.

  

 As
previously reported, the Company’s previous revolving credit facility, made available to the Company by Fifth Third Bank, N.A.,
as successor to Comerica Bank, has been terminated.

  

 Item 9.01 Financial
 Statements and Exhibits

  

 (d)
Exhibits .

  
  

 Exhibit

 Number
 Description

 10.1
 Loan Agreement, dated as of June 2, 2026, by and between the Company and CNB

 10.2
 Revolving Promissory Note, dated as of June 2, 2026, made by the Company in favor of CNB

 10.3
 Pledged Collateral and Restricted Account Agreement, dated as of June 2, 2026, by and between the Company and CNB

 10.4
 Security Agreement, dated as of June 2, 2026, by and between the Company and CNB

 104
 Cover
 Page Interactive Data File (embedded within the Inline XBRL document)

  

  

    

  

  

 SIGNATURES

 Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  
 SENSUS HEALTHCARE, INC.

  
  
  

  
  
  

 Date: June
 5, 2026
 By:
 /s/ Javier Rampolla

  
  
 Javier Rampolla

  
  
 Chief Financial Officer